CDK2 and colorectal carcinoma: The mRNA and protein levels of CDK1, but not other CDK family members, such as CDK2, CDK4, CDK6, and CDK9, were significantly upregulated in oxaliplatin‐resistant CRC tissues (Figure 1C,D; Figure S1G–K, Supporting Information).